VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 47 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,515,361 | -6.1% | 453,595 | +38.8% | 0.41% | -1.4% |
| Q2 2023 | $3,743,005 | +1244.5% | 326,900 | +805.3% | 0.42% | +1129.4% |
| Q1 2023 | $278,400 | -62.0% | 36,109 | -37.1% | 0.03% | -81.3% |
| Q4 2016 | $732,000 | -32.7% | 57,430 | -36.6% | 0.18% | -33.1% |
| Q3 2016 | $1,088,000 | +146.2% | 90,631 | +125.3% | 0.27% | +124.8% |
| Q2 2016 | $442,000 | +25.9% | 40,230 | +0.1% | 0.12% | +28.7% |
| Q1 2016 | $351,000 | – | 40,200 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
| EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
| EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
| HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
| Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
| Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
| CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
| FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 797,000 | $6,144,870 | 0.03% |